Largest pharmaceuticals by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Pfizer leads the 61 pharmaceuticals ranked by total assets, at NOK 2.02T, ahead of Johnson & Johnson (NOK 1.93T) and Sanofi (NOK 1.36T). Figures as of 18 Nov 2026, 14:51 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerNOK 2.02T
- Median
- NOK 34.2B
- Combined market value
- NOK 49.7T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | NOK 2.02T | NOK 1.56T | NOK 274.46 | 0.54% down | 14% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | NOK 1.93T | NOK 6.47T | NOK 2,685.58 | 0.59% down | 38% up | ||
| 3 | SanofiSNY · Health Care | NOK 1.36T | NOK 1.11T | NOK 460.81 | 0.02% up | 4% down | ||
| 4 | Merck & CoMRK · Health Care | NOK 1.33T | NOK 3.36T | NOK 1,362.76 | 1.94% down | 51% up | ||
| 5 | AbbVieABBV · Health Care | NOK 1.3T | NOK 4.98T | NOK 2,814.99 | 0.84% down | 26% up | ||
| 6 | AstraZenecaAZN · Health Care | NOK 1.11T | NOK 2.71T | NOK 1,748.94 | 0.98% down | 2% up | ||
| 7 | Eli LillyLLY · Health Care | NOK 1.09T | NOK 12.18T | NOK 13,674.22 | 0.34% down | 35% up | ||
| 8 | NovartisNVS · Health Care | NOK 1.08T | NOK 2.88T | NOK 1,524.34 | 1.18% down | 25% up | ||
| 9 | Takeda PharmaceuticalTAK · Health Care | NOK 941.7B | NOK 666.1B | NOK 208.50 | 0.62% down | 54% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | NOK 872.8B | NOK 1.2T | NOK 587.70 | 1.22% down | 34% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | NOK 840.5B | NOK 1.76T | NOK 1,015.45 | 0.00% | 17% down | ||
| 12 | GSKGSK · Health Care | NOK 786.4B | NOK 956.5B | NOK 477.19 | 0.02% down | 6% up | ||
| 13 | Novo NordiskNVO · Health Care | NOK 780.9B | NOK 1.71T | NOK 388.89 | 1.43% down | 17% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | NOK 395B | NOK 483.9B | NOK 414.72 | 0.41% up | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | NOK 393.1B | NOK 964.1B | NOK 9,319.29 | 0.38% up | 36% up | ||
| 16 | ViatrisVTRS · Health Care | NOK 360.5B | NOK 228B | NOK 198.87 | 0.32% up | 96% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | NOK 248.6B | NOK 1.32T | NOK 5,202.27 | 0.47% up | 27% up | ||
| 18 | GrifolsGRFS · Health Care | NOK 212B | NOK 57.1B | NOK 83.85 | 0.23% up | 1% up | ||
| 19 | Royalty PharmaRPRX · Health Care | NOK 190.2B | NOK 382.2B | NOK 664.66 | 0.16% down | 78% up | ||
| 20 | ZoetisZTS · Health Care | NOK 149.9B | NOK 332B | NOK 817.13 | 0.98% up | 29% down | ||
| 21 | Elanco Animal HealthELAN · Health Care | NOK 129.5B | NOK 126.5B | NOK 253.09 | 1.01% up | 20% up | ||
| 22 | GenmabGMAB · Health Care | NOK 124.8B | NOK 309B | NOK 501.14 | 0.50% down | 70% up | ||
| 23 | Jazz PharmaceuticalsJAZZ · Health Care | NOK 113B | NOK 149.8B | NOK 2,334.33 | 0.05% up | 37% up | ||
| 24 | BeOne MedicinesONC · Health Care | NOK 79.4B | NOK 450.4B | NOK 3,942.98 | 1.57% down | 17% up | ||
| 25 | United TherapeuticsUTHR · Health Care | NOK 76.4B | NOK 239.7B | NOK 5,628.62 | 0.59% down | 23% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | NOK 73.6B | NOK 110.2B | NOK 568.99 | 0.32% up | 11% up | ||
| 27 | Dr. Reddy's LaboratoriesRDY · Health Care | NOK 59.8B | NOK 120.9B | NOK 145.01 | 1.15% up | 5% up | ||
| 28 | Roivant SciencesROIV · Health Care | NOK 55.3B | NOK 271.1B | NOK 374.16 | 0.28% down | 90% up | ||
| 29 | Alnylam PharmaceuticalsALNY · Health Care | NOK 48.1B | NOK 200.7B | NOK 1,498.17 | 1.24% down | 66% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | NOK 35.7B | NOK 71.5B | NOK 205.30 | 0.28% up | 83% up | ||
| 31 | Ionis PharmaceuticalsIONS · Health Care | NOK 34.2B | NOK 43.7B | NOK 262.46 | 0.43% up | 64% down | ||
| 32 | PTC TherapeuticsPTCT · Health Care | NOK 28.1B | NOK 48.6B | NOK 581.88 | 0.55% down | 20% down | ||
| 33 | AlkermesALKS · Health Care | NOK 24.1B | NOK 75.2B | NOK 447.73 | 1.63% up | 58% up | ||
| 34 | InsmedINSM · Health Care | NOK 22B | NOK 257.8B | NOK 1,175.00 | 0.53% down | 40% down | ||
| 35 | Legend BiotechLEGN · Health Care | NOK 16.8B | NOK 31.1B | NOK 160.09 | 2.52% up | 42% down | ||
| 36 | Ligand PharmaceuticalsLGND · Health Care | NOK 15.1B | NOK 56.9B | NOK 2,846.98 | 0.03% down | 43% up | ||
| 37 | Ascendis PharmaASND · Health Care | NOK 14B | NOK 170.2B | NOK 2,595.24 | 1.27% down | 28% up | ||
| 38 | CytokineticsCYTK · Health Care | NOK 13.8B | NOK 70.1B | NOK 502.98 | 0.46% up | 20% down | ||
| 39 | Arrowhead PharmaceuticalsARWR · Health Care | NOK 13.4B | NOK 58.7B | NOK 415.50 | 0.29% down | 10% up | ||
| 40 | Madrigal PharmaceuticalsMDGL · Health Care | NOK 12.2B | NOK 93.6B | NOK 4,029.17 | 1.50% down | 24% down | ||
| 41 | TG TherapeuticsTGTX · Health Care | NOK 10.3B | NOK 92B | NOK 608.44 | 0.10% up | 107% up | ||
| 42 | Praxis Precision MedicinesPRAX · Health Care | NOK 9.1B | NOK 82.6B | NOK 2,954.23 | 0.09% down | 61% up | ||
| 43 | Cogent BiosciencesCOGT · Health Care | NOK 9.1B | NOK 47.6B | NOK 273.85 | 1.44% up | 20% down | ||
| 44 | BridgeBio PharmaBBIO · Health Care | NOK 9.1B | NOK 144.5B | NOK 741.87 | 0.35% down | 17% up | ||
| 45 | Mirum PharmaceuticalsMIRM · Health Care | NOK 8.2B | NOK 58.2B | NOK 891.62 | 0.04% up | 31% up | ||
| 46 | Corcept TherapeuticsCORT · Health Care | NOK 8.1B | NOK 73.6B | NOK 672.07 | 1.05% down | 8% down | ||
| 47 | Belite BioBLTE · Health Care | NOK 7.6B | NOK 62.6B | NOK 1,541.21 | 0.81% up | 31% up | ||
| 48 | Spyre TherapeuticsSYRE · Health Care | NOK 7.5B | NOK 87B | NOK 916.10 | 0.75% up | 286% up | ||
| 49 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | NOK 7.4B | NOK 73.7B | NOK 937.71 | 1.71% up | 126% up | ||
| 50 | Summit TherapeuticsSMMT · Health Care | NOK 7.3B | NOK 83.2B | NOK 104.01 | 0.56% up | 36% down | ||
| 51 | Axsome TherapeuticsAXSM · Health Care | NOK 6.7B | NOK 68.5B | NOK 1,301.40 | 1.24% down | 7% down | ||
| 52 | Protagonist TherapeuticsPTGX · Health Care | NOK 6.5B | NOK 78.5B | NOK 1,203.02 | 0.45% down | 46% up | ||
| 53 | ABIVAXABVX · Health Care | NOK 6.3B | NOK 70.8B | NOK 808.65 | 1.61% up | 27% down | ||
| 54 | Travere TherapeuticsTVTX · Health Care | NOK 5.9B | NOK 46.8B | NOK 487.86 | 1.51% down | 44% up | ||
| 55 | Edgewise TherapeuticsEWTX · Health Care | NOK 5.4B | NOK 43.5B | NOK 397.71 | 2.40% down | 88% up | ||
| 56 | Dianthus TherapeuticsDNTH · Health Care | NOK 5.1B | NOK 47.3B | NOK 839.67 | 0.41% down | 113% up | ||
| 57 | Oruka TherapeuticsORKA · Health Care | NOK 4.7B | NOK 64B | NOK 944.21 | 1.13% up | 241% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | NOK 4.7B | NOK 77.2B | NOK 1,113.84 | 1.46% down | 13% up | ||
| 59 | Definium TherapeuticsDFTX · Health Care | NOK 4.3B | NOK 38.8B | NOK 283.62 | 0.41% down | 169% up | ||
| 60 | ErascaERAS · Health Care | NOK 3.8B | NOK 45.7B | NOK 130.08 | 3.38% down | 403% up | ||
| 61 | VeradermicsMANE · Health Care | NOK 1.5B | NOK 51.8B | NOK 1,226.67 | 0.72% up | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 9.6931 NOK).
Questions and answers
Which pharmaceuticals rank first by total assets?
Pfizer (NOK 2.02T), Johnson & Johnson (NOK 1.93T) and Sanofi (NOK 1.36T) are the top three of the 61 pharmaceuticals ranked by total assets as of 18 Nov 2026, 14:51 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by total assets.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by total assets have a combined market value of NOK 49.7T as of 18 Nov 2026, 14:51 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.